Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

UC San Francisco neurologists focus on the hazards of abortion restrictions for women of reproductive age

UCSF Perspective Article Says New Ruling May Result in Increased Risk of Deaths, Disability.

14 Jul 2022

Study provides detailed understanding of SARS-CoV-2 Omicron sublineage antibody escape

A new study reveals the antibody-mediated neutralization of both current and emerging Omicron subvariants.

13 Jul 2022

Study suggests ZCB11 as a promising antibody drug against all SARS-CoV-2 variants of concern

Researchers at the AIDS Institute, The University of Hong Kong, Department of Microbiology, School of Clinical Medicine, the LKS Faculty of Medicine of The University of Hong Kong and the State Key Laboratory of Emerging Infectious Diseases, HKU, together with structural biologists at The Hong Kong University of Science and Technology, have demonstrated that ZCB11, a broadly neutralizing antibody derived from a local mRNA-vaccinee against the spreading Omicron variants of SARS-CoV-2, displays potent antiviral activities against all variants of concern (VOCs), including the dominantly spreading Omicron BA.1, BA1.1 and BA.2.

13 Jul 2022

Pfizer’s SARS-CoV-2 vaccine does not affect the honeymoon phase of type 1 diabetes

In a new study, researchers reported that Pfizer’s BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 does not affect the honeymoon phase of type 1 diabetes (T1D).

13 Jul 2022

The potential of tixagevimab–cilgavimab for treating hospitalized COVID-19 patients

Scientists assessed the potential of tixagevimab–cilgavimab for treating hospitalized SARS-CoV-2 patients.

13 Jul 2022

Doggybone DNA COVID-19 vaccine can effectively neutralize SARS-CoV-2 variants

Researchers assessed the efficacy of the novel SARS-CoV-2 doggybone deoxyribonucleic acid (DNA) vaccine.

13 Jul 2022

Immunoglobulin G isotypes switch class following repeated SARS-CoV-2 mRNA vaccination

Researchers reported a class switch in SARS-CoV-2-specific antibodies due to repeated mRNA vaccinations.

13 Jul 2022

Booster dose of SARS-CoV-2 vaccine benefits lupus patients

People with systemic lupus erythematosus, or SLE, who received a "booster" dose of SARS-CoV-2 vaccine after full vaccination are roughly half as likely to have a subsequent "breakthrough" COVID-19 infection, a new study shows.

13 Jul 2022

Production of anti-SARS-CoV-2 antibodies from hyperimmunized chickens

A new study reports the production of neutralizing antibodies against SARS-CoV-2 in hyperimmunized hens.

12 Jul 2022

Scientists explore antigenic imprinting in SARS-CoV-2

A recently published study compared monoclonal RBD antibody responses induced by SARS-CoV-2 Beta variant infections to antibodies induced by the ancestral virus in immunologically naive subjects.

12 Jul 2022

Scientists determine the binding affinity of anti-SARS-CoV-2 antibodies in response to infection or vaccination

Scientists measured the quantity and binding affinity (avidity) of antibodies against five different viral proteins.

12 Jul 2022

What is the long-term protection against COVID-19?

A new study describes the immunologic parameters associated with protection from COVID-19.

12 Jul 2022

SARS-CoV-2 Omicron BA.5 tropism shifting back to ancestral strains

In a recent study posted to the medRxiv* pre-print server, researchers from Australia and Switzerland gathered data to help track and manage ongoing and future infection waves by new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC) Omicron globally.

12 Jul 2022

Scientists investigate impact of SARS-CoV-2 RBD mutations across variants

In a recent study posted to the medRxiv* pre-print server, Australian researchers comprehensively investigated the impact of 39 receptor-binding-domain (RBD) mutations in six severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and variants of interest (VOIs).

12 Jul 2022

Persistence of SARS-CoV-2 in tissues leads to long COVID

PASC is likely the result of long-term persistence of SARS-CoV-2 in various tissues

11 Jul 2022

UT Southwestern researchers reveal the physical mechanism behind a neurological autoimmune disease

Using UT Southwestern's Cryo-Electron Microscopy Facility, researchers for the first time have captured images of an autoantibody bound to a nerve cell surface receptor, revealing the physical mechanism behind a neurological autoimmune disease.

11 Jul 2022

Immune response after mild COVID

In a recent study posted to the medRxiv* preprint server, researchers in Germany assessed the immunity elicited by a mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

10 Jul 2022

Monoclonal antibody treatment taken by hospitalized COVID-19 patients reduces mortality

A monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths, according to a study published July 8 in The Lancet Respiratory Medicine.

8 Jul 2022

Scientists gain unprecedented insight into the key properties of antibody needed to combat cancer

Researchers at the University of Southampton have gained unprecedented new insight into the key properties of an antibody needed to fight off cancer.

8 Jul 2022

Disrupting genes in the yeast Pichia pastori to increase its secretory production of useful proteins

A collaboration including researchers from Kobe University, University of Tokyo and Tohoku University has successfully identified and disrupted genes in the yeast Pichia pastoris (1) in order to increase its secretory production of useful proteins (2).

8 Jul 2022

Antibody News and Research

Further Reading

UC San Francisco neurologists focus on the hazards of abortion restrictions for women of reproductive age

Study provides detailed understanding of SARS-CoV-2 Omicron sublineage antibody escape

Study suggests ZCB11 as a promising antibody drug against all SARS-CoV-2 variants of concern

Pfizer’s SARS-CoV-2 vaccine does not affect the honeymoon phase of type 1 diabetes

The potential of tixagevimab–cilgavimab for treating hospitalized COVID-19 patients

Doggybone DNA COVID-19 vaccine can effectively neutralize SARS-CoV-2 variants

Immunoglobulin G isotypes switch class following repeated SARS-CoV-2 mRNA vaccination

Booster dose of SARS-CoV-2 vaccine benefits lupus patients

Production of anti-SARS-CoV-2 antibodies from hyperimmunized chickens

Scientists explore antigenic imprinting in SARS-CoV-2

Scientists determine the binding affinity of anti-SARS-CoV-2 antibodies in response to infection or vaccination

What is the long-term protection against COVID-19?

SARS-CoV-2 Omicron BA.5 tropism shifting back to ancestral strains

Scientists investigate impact of SARS-CoV-2 RBD mutations across variants

Persistence of SARS-CoV-2 in tissues leads to long COVID

UT Southwestern researchers reveal the physical mechanism behind a neurological autoimmune disease

Immune response after mild COVID

Monoclonal antibody treatment taken by hospitalized COVID-19 patients reduces mortality

Scientists gain unprecedented insight into the key properties of antibody needed to combat cancer

Disrupting genes in the yeast Pichia pastori to increase its secretory production of useful proteins

eBook: End-to-end solutions for bispecific antibody development eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo